• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶D:一种参与乳腺癌转移的蛋白酶。

Cathepsin D: a protease involved in breast cancer metastasis.

作者信息

Rochefort H, Capony F, Garcia M

机构信息

Unité Hormones et Cancer (U 148) INSERM, University of Montpellier, France.

出版信息

Cancer Metastasis Rev. 1990 Dec;9(4):321-31. doi: 10.1007/BF00049522.

DOI:10.1007/BF00049522
PMID:1965795
Abstract

Cathepsin D is an acidic lysosomal protease present in all cells. In estrogen receptor positive and negative breast cancer cell lines, the mRNA coding for pro-cathepsin D is overexpressed and sorting and maturation of the pro-enzyme are altered, via possibly saturation of the Man-6-P/IGF-II receptor, leading to accumulation of the active proteinase in large endosomes and to secretion of the precursor (52K protein). In MCF7 cells, the cathepsin D mRNA is induced directly and transcriptionally by estrogens and indirectly by growth factors. In patients, there is a significant correlation between high cathepsin D concentrations in the cytosol of primary breast cancer and development of metastasis. This marker is independent of other prognostic factors and appears to be particularly useful in axillary node-negative tumors. Transfection of a human cDNA cathepsin D expression vector under the control of SV40 promoter increases the metastatic potential of 3YA1-Ad12 rat tumorigenic cells when intravenously injected into nude mice. The mechanism of cathepsin D-induced metastasis is currently unknown. These results indicate that overexpression of cathepsin D might facilitate breast cancer metastasis, suggesting new possible therapeutic approaches.

摘要

组织蛋白酶D是一种存在于所有细胞中的酸性溶酶体蛋白酶。在雌激素受体阳性和阴性的乳腺癌细胞系中,编码组织蛋白酶D原的mRNA过度表达,且该酶原的分选和成熟过程发生改变,这可能是由于甘露糖-6-磷酸/胰岛素样生长因子II受体饱和所致,从而导致活性蛋白酶在大的内体中积累以及前体(52K蛋白)的分泌。在MCF7细胞中,组织蛋白酶D的mRNA由雌激素直接转录诱导,并由生长因子间接诱导。在患者中,原发性乳腺癌细胞溶质中高浓度的组织蛋白酶D与转移的发生显著相关。该标志物独立于其他预后因素,在腋窝淋巴结阴性肿瘤中似乎特别有用。当将在SV40启动子控制下的人组织蛋白酶D cDNA表达载体转染的3YA1-Ad12大鼠致瘤细胞静脉注射到裸鼠体内时,其转移潜能会增加。目前尚不清楚组织蛋白酶D诱导转移的机制。这些结果表明,组织蛋白酶D的过度表达可能促进乳腺癌转移,提示了新的可能治疗方法。

相似文献

1
Cathepsin D: a protease involved in breast cancer metastasis.组织蛋白酶D:一种参与乳腺癌转移的蛋白酶。
Cancer Metastasis Rev. 1990 Dec;9(4):321-31. doi: 10.1007/BF00049522.
2
Cathepsin D in breast cancer.乳腺癌中的组织蛋白酶D
Breast Cancer Res Treat. 1990 Jul;16(1):3-13. doi: 10.1007/BF01806570.
3
Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.乳腺癌中的组织蛋白酶D:从分子与细胞生物学到临床应用
Cancer Cells. 1990 Dec;2(12):383-8.
4
Biological and clinical significance of cathepsin D in breast cancer metastasis.组织蛋白酶D在乳腺癌转移中的生物学及临床意义
Stem Cells. 1996 Nov;14(6):642-50. doi: 10.1002/stem.140642.
5
Biological and clinical significance of cathepsin D in breast cancer.组织蛋白酶D在乳腺癌中的生物学及临床意义
Semin Cancer Biol. 1990 Apr;1(2):153-60.
6
Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.乳腺癌细胞分泌的52K组织蛋白酶D前体的结构、功能、调节及临床意义
Biochimie. 1988 Jul;70(7):943-9. doi: 10.1016/0300-9084(88)90236-2.
7
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].[雌激素、组织蛋白酶D与乳腺癌和卵巢癌转移:侵袭还是增殖?]
C R Seances Soc Biol Fil. 1998;192(2):241-51.
8
[Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the metastatic process].[组织蛋白酶D基因在乳腺癌中过表达的机制及其在转移过程中的影响]
C R Seances Soc Biol Fil. 1991;185(6):415-21.
9
Regulation, clinical and biological significance of cathepsin D in breast cancer.
Rev Esp Fisiol. 1990 Mar;46(1):39-41.
10
Biological and clinical significance of cathepsin D in breast cancer.组织蛋白酶D在乳腺癌中的生物学及临床意义
Acta Oncol. 1992;31(2):125-30. doi: 10.3109/02841869209088891.

引用本文的文献

1
Explainable Machine Learning Identifies Factors for Dosage Compensation in Aneuploid Human Cancer Cells.可解释的机器学习识别非整倍体人类癌细胞中剂量补偿的因素。
bioRxiv. 2025 May 13:2025.05.12.653427. doi: 10.1101/2025.05.12.653427.
2
Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System.通过调节肾素-血管紧张素系统对癌症干细胞进行治疗靶向
Front Oncol. 2019 Aug 8;9:745. doi: 10.3389/fonc.2019.00745. eCollection 2019.
3
Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation.

本文引用的文献

1
A secreted glycoprotein induced by estrogen in human breast cancer cell lines.一种由雌激素在人乳腺癌细胞系中诱导产生的分泌型糖蛋白。
Cell. 1980 Jun;20(2):353-62. doi: 10.1016/0092-8674(80)90621-2.
2
Lysosomal cathepsin B: correlation with metastatic potential.溶酶体组织蛋白酶B:与转移潜能的相关性。
Science. 1981 Jun 5;212(4499):1151-3. doi: 10.1126/science.7233209.
3
Release of estrogen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture.原代培养的乳腺癌细胞释放分子量为52,000的雌激素诱导糖蛋白。
AKR1B10 依赖性糖酵解与脂肪酸氧化平衡实现转移性乳腺癌的代谢适应性
Nat Commun. 2019 Jun 20;10(1):2698. doi: 10.1038/s41467-019-10592-4.
4
Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.γ-生育三烯酚与冬凌草甲素联合治疗的协同抗癌作用与自噬的诱导有关。
Mol Cell Biochem. 2015 Oct;408(1-2):123-37. doi: 10.1007/s11010-015-2488-x. Epub 2015 Jun 27.
5
Disruption of lysosome function promotes tumor growth and metastasis in Drosophila.溶酶体功能的破坏促进果蝇肿瘤的生长和转移。
J Biol Chem. 2010 Jul 9;285(28):21817-23. doi: 10.1074/jbc.M110.131714. Epub 2010 Apr 25.
6
Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging.线粒体周转和长寿命有丝分裂后细胞的衰老:衰老的线粒体-溶酶体轴理论。
Antioxid Redox Signal. 2010 Apr;12(4):503-35. doi: 10.1089/ars.2009.2598.
7
IGF binding proteins (IGFBPs) and regulation of breast cancer biology.胰岛素样生长因子结合蛋白(IGFBPs)与乳腺癌生物学的调控
J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):455-69. doi: 10.1007/s10911-008-9106-4. Epub 2008 Nov 25.
8
Lysosomes in iron metabolism, ageing and apoptosis.溶酶体在铁代谢、衰老和细胞凋亡中的作用
Histochem Cell Biol. 2008 Apr;129(4):389-406. doi: 10.1007/s00418-008-0394-y. Epub 2008 Feb 8.
9
Regulation of the human cathepsin E gene by the constitutive androstane receptor.组成型雄烷受体对人组织蛋白酶E基因的调控
Arch Biochem Biophys. 2007 Nov 1;467(1):132-8. doi: 10.1016/j.abb.2007.08.001. Epub 2007 Aug 19.
10
A role for small GTPase RhoA in regulating intracellular membrane traffic of lysosomes in invasive rat hepatoma cells.小GTP酶RhoA在调节侵袭性大鼠肝癌细胞溶酶体的细胞内膜运输中的作用。
Histochem J. 2002 May;34(5):189-213. doi: 10.1023/a:1021702812146.
Cancer Res. 1983 Apr;43(4):1861-8.
4
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines.抗雌激素对MCF7细胞以及两个他莫昔芬耐药亚系中雌激素调节的pS2 RNA和52千道尔顿及160千道尔顿蛋白质的影响。
J Biol Chem. 1984 Aug 25;259(16):10030-5.
5
Cathepsin D. Purification of isoenzymes from human and chicken liver.组织蛋白酶D。从人及鸡肝脏中纯化同工酶。
Biochem J. 1970 Apr;117(3):601-7. doi: 10.1042/bj1170601.
6
Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.雌激素调节的52K蛋白对MCF 7乳腺癌细胞的自分泌生长刺激作用。
Endocrinology. 1986 Apr;118(4):1537-45. doi: 10.1210/endo-118-4-1537.
7
Cloning and sequence analysis of cDNA for human cathepsin D.人组织蛋白酶D的cDNA克隆与序列分析
Proc Natl Acad Sci U S A. 1985 Aug;82(15):4910-4. doi: 10.1073/pnas.82.15.4910.
8
Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells.雌激素调节的52,000道尔顿糖蛋白单克隆抗体的特性及其在MCF7细胞中的应用。
Cancer Res. 1985 Feb;45(2):709-16.
9
Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells.人乳腺癌细胞中受雌激素调节的52 kDa分泌型和细胞型蛋白质的纯化及初步鉴定
Eur J Biochem. 1986 Dec 1;161(2):505-12. doi: 10.1111/j.1432-1033.1986.tb10471.x.
10
Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.
Cancer Res. 1986 Jul;46(7):3734-8.